CD26 (DPP4) and CALR are involved in immune modulation and cell signaling, while B7-H3 (CD276) is a prominent immune checkpoint molecule highly expressed in melanoma and other tumors, contributing to immunosuppression and tumor progression [42,43]. Here, CD276 is linked to neoplasm.